It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2018.
2018 | Hyderabad, Telangana, India | ActiveEkvira Formulations Private Limited, a active private limited company, was established on 15 May 2018 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999TG2018PTC124483. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
Its leadership includes Madhavi Bhupal Rao (Managing Director), Manoher Rao Monari (Director). Past directors included Nageshwar Rao Bhupal Rao. It holds ₹8.70 M open charges and no settled loans. Its latest AGM occurred on 24 October 2020, with the balance sheet filed on 31 March 2020. It is based at H.No.152/B, 1St Phase Allwyn Colony, Kukatpally, Hyderabad, Telangana, 500072.
U74999TG2018PTC124483
124483
15 May 2018
₹5.00 M
₹5.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Ekvira Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhavi Bhupal Rao | Managing Director | 15 May 2018 | Current |
| Manoher Rao Monari | Director | 15 May 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 May 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ekvira Formulations Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 2361.31% increase. The company also saw a substantial improvement in profitability, with a 190.76% increase in profit. The company's net worth Soared by an impressive increase of 430.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Ekvira Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹8,700,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2019 | State Bank Of India | ₹8.70 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ekvira Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ekvira Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ekvira Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ekvira Formulations Private Limited last Annual general meeting of members was held on 24 Oct 2020 as per latest MCA records. was completed.
A charge with State Bank Of India of Rs. 8.70 M registered on 29 Aug 2019 with Charge ID 100290978 was modified on 04 Sep 2020. was recorded as a recent event.
Ekvira Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad. was recorded as a recent event.
Progress on A charge with State Bank Of India amounted to Rs. 8.70 M with Charge ID 100290978 was registered on 29 Aug 2019. was documented.
Madhavi Bhupal Rao was appointed as a Managing Director was appointed as a Managing Director on 15 May 2018 & has been associated with this company since 7 years 7 months . was recorded as a recent event.
The activity Manoher Rao Monari was appointed as a Director was appointed as a Director on 15 May 2018 & has been associated with this company since 7 years 7 months . was completed.
The CIN of Ekvira Formulations Private Limited is U74999TG2018PTC124483.
Ekvira Formulations Private Limited is headquartered at H.No.152/B, 1St Phase Allwyn Colony, Kukatpally, Hyderabad, Telangana, 500072.
Ekvira Formulations Private Limited was incorporated on 15 May 2018.
The current directors of Ekvira Formulations Private Limited are
The primary industry of Ekvira Formulations Private Limited is Manufacturing.
Ekvira Formulations Private Limited is unlisted.
The authorized capital of Ekvira Formulations Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX